ADA Scientific Sessions 2026 Abstract

Exploring Diabetes Risk Link to Insulin Resistance and Immunity–Inflammation Index in Cohort of Schizophrenia: Effects of Ginsena-115 Targeting GLP–Inflammasome Signaling

By Simon Chiu, Marina Henein

Trial in peopleInterventions

The paper

Simon Chiu, Marina Henein

London

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1644-P

doi.org/10.2337/db26-1644-p

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety